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Abstract 
Stem cell tracking is a highly important subject. Current techniques based on nanoparticle-labeling, 
such as magnetic resonance imaging, fluorescence microscopy, and micro-computed tomography, 
are plagued by limitations including relatively low sensitivity or penetration depth, involvement of 
ionizing irradiation, and potential cytotoxicity of the nanoparticles. Here we introduce a new class 
of contrast agents based on gold nanocages (AuNCs) with hollow interiors and porous walls to 
label human mesenchymal stem cells (hMSCs) for both in vitro and in vivo tracking using two-photon 
microscopy and photoacoustic microscopy. As demonstrated by the viability assay, the AuNCs 
showed negligible cytotoxicity under a reasonable dose, and did not alter the differentiation po-
tential of the hMSCs into desired lineages. We were able to image the cells labeled with AuNCs in 
vitro for at least 28 days in culture, as well as to track the cells that homed to the tumor region in 
nude mice in vivo. 
Key words: gold nanocages, nanoparticles, human mesenchymal stem cells, U87 glioblastoma, 
blood vessels, stem cell therapy. 
Introduction 
Mesenchymal stem cells (MSCs) are multipotent 
progenitor cells that can differentiate into tis-
sue-specific cell types, promote vascularization [1], 
and enhance immunosuppressive effects [2], among 
other capabilities. They are capable of migrating to 
diseased tissues naturally after injuries to accelerate 
the regeneration process [3, 4], and to tumor regions 
to participate in angiogenesis and metastasis of these 
tumors [5, 6]. Because of these remarkable capabilities, 
MSCs have recently become a platform for the 
emerging stem cell therapy that seeks to heal dam-
aged tissues [7, 8], alleviate inflammation responses 
[9], and treat cancers [10, 11]. In spite of the enormous 
therapeutic potential of MSCs, it remains a challenge 
to monitor these cells in an effort to determine their 
regenerative abilities, retention, and bio-distribution 
post-transplantation. While conventional methods 
relying on destructive means such as histology can be 
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used to follow the trafficking of the infused MSCs, 
there is an increasing demand for non-invasive stem 
cell tracking technologies. 
Nuclear imaging techniques, such as positron 
emission tomography (PET) and single-photon emis-
sion computed tomography (SPECT), provide deep, 
three-dimensional (3D) imaging with high sensitivity 
[12-14]. Nevertheless, the capabilities of these two 
modalities are limited in terms of the requirement for 
genetic modifications of the cells, the cost of radionu-
clides with short half-lives, and relatively poor reso-
lution [15]. Along with the tremendous progress of 
nanotechnology in recent years, great efforts have 
been made to develop techniques based on nanopar-
ticle-labeling of stem cells. To this end, superpara-
magnetic iron oxide (SPIO) nanoparticles and 
gadonanotubes have been used to label MSCs for 
magnetic resonance imaging (MRI) [16, 17] or X-ray 
micro-computed tomography (micro-CT) [18, 19]; and 
quantum dots have been used to label hematopoietic 
stem cells (HSCs) or MSCs for fluorescence imaging 
[20, 21]. However, these contrast agents and/or im-
aging modalities suffer from several limitations. For 
example, MRI has relatively low sensitivity and 
therefore requires a high dose of contrast agents 
[22-24], quantum dots are troubled by their potential 
toxicity to cells and tissues [25, 26], and micro-CT uti-
lizes ionizing irradiation which may cause adverse 
side effects to the cells or the body [27, 28]. 
In this study, we demonstrated the feasibility of 
labeling human MSCs (hMSCs) with a novel class of 
contrast agents based on gold nanocages (AuNCs). 
The two- and three-photon luminescence capabilities 
and strong optical absorption of AuNCs enabled us to 
quantitatively track the labeled cells using 
two-photon microscopy and photoacoustic micros-
copy, respectively. In addition to imaging hMSCs 
labeled with AuNCs in vitro, we could also locate the 
cells that migrated to glioblastoma regions formed by 
subcutaneous injection in nude mice in vivo. Labeling 
with AuNCs did not compromise the functions of 
hMSCs, and the nanoparticles could remain in the 
cells for at least 4 weeks post labeling, potentially 
enabling long-term monitoring of the cells. 
Materials and methods 
Materials 
All chemicals and solvents were obtained from 
Sigma-Aldrich (Saint Louis, MO) and used 
as-received unless otherwise noted. 
Synthesis of gold nanocages (AuNCs) 
The AuNCs were prepared through a galvanic 
replacement reaction between silver nanocubes and 
chloroauric acid (HAuCl4) in an aqueous solution 
according to our previously published protocol [29]. 
The samples were characterized using a transmission 
electron microscope (TEM, FEI Spirit, Hillsboro, OR) 
operated at 120 kV. The UV-visible (UV-vis) extinc-
tion spectra were recorded using a Cary 50 spectrom-
eter (Varian, Palo Alto, CA). 
Cell culture and labeling 
The hMSCs were obtained from Lonza (Walk-
ersville, MD), and maintained in a Dulbecco's Modi-
fied Eagle Medium (DMEM, Invitrogen, Carlsbad, 
CA) supplemented with 20 vol.% fetal bovine serum 
(FBS, American Type Culture Collection, ATCC, Ma-
nassas, VA) and 1 vol.% penicillin-streptomycin (P/S, 
Invitrogen) at 37 °C and 5 vol.% CO2. To label with 
AuNCs, the cells were seeded into the wells of 6-well 
plates at a density of 5 × 105 cells per well. When con-
fluent, the medium in each well was aspirated and 2 
mL of fresh culture medium containing AuNCs was 
added. The cells were incubated with AuNCs for a 
pre-determined period of time, and the medium was 
then removed, followed by washing with fresh me-
dium 3 times. The cells were detached and dissociated 
by treatment with trypsin (Invitrogen) for further ex-
periments. 
Inductively coupled plasma mass spectrome-
try (ICP-MS) 
The hMSCs were seeded in the wells of 6-well 
plates at a density of 5 × 105 cells per well and allowed 
to grow to confluence. The cells were then incubated 
with a culture medium (2 mL per well) containing 
AuNCs at a particle concentration of 25 pM. At dif-
ferent time intervals, the cells were washed 3 times 
with cold phosphate buffered saline (PBS, Invitrogen), 
detached by treating with trypsin and the cell number 
was counted using a hemocytometer. The cell pellets 
were collected by centrifugation, lyophilized, and 
placed in centrifuge tubes (one pellet per tube). Then 
400 µL of aqua regia was added to each tube to com-
pletely dissolve the cells and the AuNCs. The amount 
of Au was measured by Elan DRC II ICP-MS (Perkin 
Elmer, Waltham, MA), and combined with the geo-
metric dimensions of AuNCs to calculate the number 
of AuNCs, which was then normalized to the number 
of cells. 
Measurement of cytotoxicity 
The cells were seeded into the wells of a 96-well 
plate at a density of 1 × 104 cells per well, incubated 
with AuNCs at various concentrations for different 
periods of time, and cell viability was measured using 
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the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazo-
lium bromide (MTT) assay. Briefly, 10 µL of 5 wt.% 
MTT (Invitrogen) in PBS was added to each well, and 
incubated for 1 h. The medium was then withdrawn, 
and 100 µL of isopropanol was added to each well to 
completely dissolve the formazan crystals. To avoid 
possible interference from the absorption of AuNCs, 
the solution in each well was centrifuged at 11,000 
rpm for 10 min, and the supernatant was added into 
the wells of a new 96-well plate. The absorbance was 
measured at 562 nm using a spectrophotometer (Infi-
nite 200, TECAN, Durham, NC). 
Membrane integrity was measured using the 
Vybrant® Cytotoxicity Assay Kit (Invitrogen) accord-
ing to the manufacturer’s instructions, which detects 
glucose-6-phosphate dehydrogenase (G6PD) released 
into the surrounding medium from the damaged 
cells. 
TEM of cells 
The hMSCs were seeded in the wells of 6-well 
plates at a density of 5 × 105 cells per well and allowed 
to grow to confluence. The cells were then incubated 
with a culture medium (2 mL per well) containing 
AuNCs at a particle concentration of 25 pM. The cells 
were collected by trypsin treatment after 24 h of in-
cubation, and centrifuged at 1000 rpm for 5 min in a 
1.5 mL Eppendorf tube. The cell pellet was then fixed 
in 4 wt.% paraformaldehyde and 2.5 wt.% glutaral-
dehyde in 0.1 M sodium cacodylate buffer for 2 h, 
followed by 3 washes with 0.1 M sodium cacodylate 
buffer and then dehydration in a graded ethanol se-
ries. The sample was placed in pure propylene oxide 
for 30 min, a mixture of propylene oxide and Em-
bed-812 resin (1:1 volume ratio) overnight, pure Em-
bed-812 resin overnight, and then cured in a rectan-
gular mold at 60 °C for 12 h. The sample was sec-
tioned at a thickness of 50–100 nm using a Leica Ul-
tramicrotome EMUC7 (Leica Microsystems Inc., Buf-
falo Grove, IL), stained in sequence with 4 wt.% ura-
nyl acetate aqueous solution for 10 min and 2 wt.% 
lead citrate aqueous solution for 2 min, and then ob-
served under a TEM at 80–120 kV. All the chemicals 
used in this section were obtained from Electron Mi-
croscopy Sciences (Hatfield, PA). 
Adipogenesis and osteogenesis of hMSCs 
To induce adipogenesis, the hMSCs were cul-
tured in a regular medium supplemented with 0.5 
mM 3-isobutyl-1-methylxanthine, 1 µM dexame-
thasone, 5 µg/mL insulin, and 50 µM indomethacin. 
Osteogenesis was induced by culturing the hMSCs in 
a regular medium supplemented with 10 mM 
β-glycerol phosphate, 300 µM L-ascorbic acid, and 100 
nM dexamethasone. The medium was changed every 
other day up to a total of 28 days. 
In vitro two-photon microscopy 
The two-photon laser scanning confocal micro-
scope was based on Zeiss LSM 510 Meta NLO system 
with a Coherent Chameleon Ti:Sapphire laser, cou-
pled to an upright Zeiss Axioskop 2 microscope (Carl 
Zeiss Microscopy, Thornwood, NY). 
The hMSCs labeled with AuNCs (incubation 
condition: 25 pM for 24 h) were seeded onto sterile 
cover glasses, and re-passaging was performed if 
necessary when the cells had reached high density. 
The cells were fixed using 3.7 vol.% formaldehyde in 
PBS at days 1, 3 and 7 post seeding, and subjected to 
two-photon imaging at an excitation wavelength of 
800 nm. The photoluminescence intensity of the cells 
at each time point was obtained by averaging at least 
20 cells from multiple images. The laser power at dif-
ferent time points did not show variations larger than 
1%. 
In vitro photoacoustic microscopy 
The hMSCs labeled with AuNCs were prepared 
the same way as those for two-photon microscopy. 
The integrated optical-resolution photoacoustic and 
fluorescence confocal microscopy system employed a 
dye laser (CBR-D, Sirah) with a wavelength tunable in 
the range of 560–590 nm (Rhodamine 6G, Exciton), 
pumped by a 523-nm Nd:YLF laser (INNOSLAB, 
Edgewave) [30]. The laser beam (excitation wave-
length: 570 nm) was focused onto the sample by an 
objective lens (NA: 0.2; magnification: 13.3). The 
photoacoustic waves were detected using a 50-MHz 
ultrasonic transducer (V214-BB-RM, Olympus NDT, 
Kennewick, WA). The lateral resolution was meas-
ured to be approximately 5 µm in water. The ampli-
fied photoacoustic signals were digitized and saved 
along with the laser fluence signals by a DAQ in-
strument (CS 14200, Gage Applied Technologies, 
Canada). Two-dimensional (2D) en face photoacoustic 
images were rendered by raster scanning of the sam-
ple on the x-y transverse plane.  
The subwavelength-resolution photoacoustic 
system utilized an Nd:YVO4 laser as the irradiation 
source [31]. The laser generated 532-nm pulses with 
1.5-ns duration, which were transmitted to the optical 
objective through a single-mode optical fiber. The 
objective lens had an NA of 0.60, providing a lateral 
resolution of approximately 0.4 µm. The samples ir-
radiated by focused laser pulses generated photoa-
coustic waves, which were detected in transmission 
mode by an ultrasonic transducer with a central fre-
quency of 40 MHz and an NA of 0.5. The photoa-
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coustic signals were then amplified, digitized at a 
sampling rate of 1 GHz, and processed by a computer 
for image processing. 2D en face photoacoustic images 
were rendered by raster scanning of the objective and 
the transducer on the x-y transverse plane. 
A deep reflection-mode photoacoustic imaging 
system utilized a tunable Ti:Sapphire laser (LT-2211A; 
Lotis TII, Minsk, Belarus) pumped by a Q-switched 
Nd:YAG laser (LS-2137; Lotis TII) for photoacoustic 
excitation at a wavelength of 800 nm (pulse width: 5 
ns, pulse repetition rate: 10 Hz) [32]. A 5-MHz central 
frequency, spherically focused ultrasonic transducer 
(V308; Panametrics-NDT, Waltham, MA, USA) was 
used to acquire the photoacoustic signals generated 
from the sample. The 5-MHz transducer yielded axial 
and transverse resolutions of 150 and 560 µm, respec-
tively. The signals were amplified by a low-noise 
amplifier (5072PR; Panametrics-NDT) and recorded 
using a digital oscilloscope (TDS 5054; Tektronix, 
Beaverton, OR). 2D en face photoacoustic images were 
generated by raster scanning of the objective and the 
transducer on the x-y transverse plane. 
In vivo tracking of hMSCs homed to tumor re-
gions 
All animal experiments were performed in ac-
cordance with protocols approved by the Washington 
University Department of Comparative Medicine and 
the Animal Studies Committee. Athymic Nude mice 
4–5 weeks old were obtained from Harlan and housed 
under speciﬁc pathogen-free conditions in the animal 
facility at Washington University. About 5 µL of PBS 
containing approximately 1 × 105 U87-MG glioblas-
toma cells was injected subcutaneously in the left ear 
of each mouse. The tumors were allowed to grow for 1 
week to develop blood vessels inside the tumor re-
gions. Then 100 µL of PBS containing approximately 1 
× 105 hMSCs labeled with AuNCs was injected intra-
venously through the tail vein of each mouse. Imag-
ing was performed using two-photon microscopy or 
photoacoustic microscopy at 1 week post injection of 
the hMSCs. For two-photon microscopy, blood ves-
sels were further labeled by intravenous injection of 
50 µL of rhodamine-dextran (M.W. 100,000,000, 10 
mg/mL in PBS) and imaged using the confocal con-
figuration at an excitation wavelength of 530 nm. The 
hMSCs labeled with AuNCs were detected by the 
two-photon configuration at an excitation wavelength 
of 800 nm. For photoacoustic microscopy (see below 
for details), dual wavelength imaging was carried out 
at 532 nm (for blood vessels) and 638 nm (for hMSCs 
labeled with AuNCs).  
 A recently developed voice-coil opti-
cal-resolution photoacoustic microscopy was em-
ployed [33]. The system was consisted of a photoa-
coustic probe and a voice-coil-based scanner. In the 
photoacoustic probe, a custom-made photoacoustic 
beam combiner was utilized to merge the optical and 
acoustic beams. Short laser pulses were focused onto 
the sample through a set of lenses. The excited pho-
toacoustic waves were collected by an ultrasound lens 
(6-mm aperture, 0.5-NA in water) and received by a 
high-frequency ultrasound transducer (V214-BC, 
Olympus NDT, Waltham, MA). To achieve high sen-
sitivity, the optical and acoustic foci were confocally 
and coaxially aligned. The photoacoustic probe was 
mounted onto the voice-coil-based scanner 
(VCS-1010, Equipment Solutions, Sunnyvale, CA) to 
implement fast imaging, which could achieve a 20-Hz 
cross-sectional imaging speed over a range of several 
millimeters. The lateral resolution was measured to be 
3.4 µm in water. 2D en face photoacoustic images were 
generated by raster scanning of the objective and the 
transducer on the x-y transverse plane. 
For histology analysis, the tumors in a parallel 
group were explanted at 1 week post injection of the 
hMSCs, ﬁxed in 3.7 vol.% formaldehyde in PBS, de-
hydrated in a graded ethanol series, embedded in 
paraffin and sectioned using a microtome (5 µm in 
thickness). The samples were stained with hematoxy-
lin/eosin and observed under Nanozoomer Virtual 
Digital Microscopy (Hamamatsu, Bridgewater, NJ). 
Results 
AuNCs and cell uptake 
As shown in Figure 1A, the AuNCs had an edge 
length of around 45 nm. They did not induce re-
markable cytotoxicity towards hMSCs as revealed by 
the high (>80%) viability of the cells after incubation 
with AuNCs for 24 h at concentrations up to 50 pM, or 
at a concentration of 25 pM for up to 48 h (Figure 1B). 
The uptake of AuNCs by the cells also did not com-
promise their membrane integrity, as measured by 
quantifying the release of G6PD from the cells into the 
surrounding medium (Supplementary Material: Fig-
ure S1). Figure 1C shows the two-photon lumines-
cence spectrum of AuNCs as recorded using a micro-
scope [34]. The AuNCs had strong photoluminescence 
in the spectral range of approximately 400–700 nm. 
Figure 1D shows UV-vis extinction spectra of AuNCs 
in comparison with hemoglobin. While AuNCs had 
an absorption peak around 800 nm, the major absorp-
tion peaks for both oxygenated and deoxygenated 
hemoglobin fell in the range of below 600 nm. 
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Fig 1. (A) A transmission electron micrograph showing AuNCs with an edge length of around 45 nm. (B) Cell viability data of AuNCs when they were 
incubated with hMSCs at a concentration of 25 pM for up to 48 h (left) or for 24 h at various concentrations up to 200 pM (right). (C) Photoluminescence 
spectrum of AuNCs measured using two-photon microscopy. (D) UV-vis extinction spectra of AuNCs, oxygenated hemoglobin (HbO2) and deoxygenated 
hemoglobin (Hb). Note that the extinction peak of AuNCs was located at a wavelength distinct from that of either HbO2 or Hb. 
 
TEM observation confirmed the uptake of 
AuNCs by hMSCs (Supplementary Material: Figure 
S2). Most AuNCs were enclosed in endosome-like 
structures. No AuNCs were found inside the nucleus. 
It could also be observed in a magnified image (Fig-
ure S2, inset) that the morphology of the AuNCs was 
not altered after their uptake by the cells. As shown in 
Supplementary Material: Figure S3, the uptake of 
AuNCs by hMSCs was linearly correlated with the 
incubation period as determined by ICP-MS (R2 = 
0.9788). An incubation time of 24 h at a concentration 
of 25 pM AuNCs were used for the following exper-
iments, because under such a condition the uptake of 
AuNCs by the cells could reach a sufficient amount 
(approximately 2.3 × 104 AuNCs per cell) to generate 
strong enough two-photon or photoacoustic signals 
while maintaining high viability of the cells. 
The AuNCs could retain in the cells for at least 
28 days of culture (Supplementary Material: Figure 
S4A). During the culture period, there was negligible 
exocytosis of AuNCs by the cells as determined by a 
translocation assay, since hMSCs incubated with the 
medium collected from cultures of cells labeled with 
AuNCs did not effectively generate two-photon sig-
nals (Figure S4B). 
Differentiation of hMSCs 
To further investigate the cytotoxicity of AuNCs, 
labeled or un-labeled hMSCs were induced for adi-
pogenesis and osteogenesis. For both labeled (Figure 
2, A, C, E and G) and un-labeled (Figure 2, B, D, F and 
H) hMSCs, large amounts of oil droplets or mineral 
were found to form after 4 weeks of differentiation 
into adipose (Figure 2, A–D) or bone (Figure 2, E–H) 
lineages. The degree of differentiation was then 
quantified. As shown in Figure 2, I and J, the presence 
of AuNCs inside hMSCs did not affect their capability 
to differentiate into different cell lineages. 
The AuNCs could also retain in the cells after 
they had been induced for differentiation for 28 days 
(Supplementary Material: Figure S5). Some AuNCs 
were observed to co-localize with oil droplets during 
adipogenesis (Figure S5, A and B), or with mineral 
deposits during osteogenesis (Figure S5, C and D). 
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In vitro two-photon and photoacoustic mi-
croscopy of hMSCs labeled with AuNCs 
Phantom experiments were carried out by im-
aging suspensions of AuNCs at different concentra-
tions sealed in glass capillaries with a two-photon or 
an optical-resolution photoacoustic microscope. As 
shown in Figure 3, A and B, the two-photon intensity 
and photoacoustic amplitude both showed linear 
correlations with the concentration of AuNCs (R2 = 
0.9948 and 0.9968, respectively). The hMSCs labeled 
with AuNCs could be clearly imaged at high resolu-
tions by both two-photon (Supplementary Material: 
Figure S6A) and photoacoustic microscopy (Figure 
S6B, the subwavelength-resolution system). It was 
also found that, as the initially labeled cells divided, 
AuNCs were diluted into their decedent cells, leading 
to linearly decreased two-photon intensity or photo-
acoustic amplitude (Figure 3, C and D) over a culture 
period of 7 days. 
As shown in Supplementary Material: Figure 
S7A, hMSCs labeled with AuNCs could be detected 
when embedded deeply in tissues (over 5 mm, 
chicken breast) using an acoustic-resolution photoa-
coustic microscopy at the expense of decreasing lat-
eral resolution to approximately 100 µm. As expected, 
at the same depth, photoacoustic amplitude was lin-
early correlated with the number of hMSCs labeled 
with AuNCs (Figure S7A), and at the same density of 
AuNCs-labeled cells, photoacoustic amplitude fol-
lowed exponential decay against the depth (Figure 
S7B). 
 
 
Fig 2. (A, B) Oil red staining showing the formation of oil drops in the hMSCs induced for adipogenesis for 4 weeks; (C, D) are magnified views of (A, B), 
respectively. (E, F) Alizarin red staining showing the formation of calcium deposits in the hMSCs induced for osteogenesis for 4 weeks. (G, H) are magnified 
views of (E, F), respectively. The hMSCs in (A, C, E, and G) were labeled with AuNCs while those in (B, D, F, and H) were unlabeled. (I, J) Quantification 
of oil red uptake in the adipogenesis group and alizarin red uptake in the osteogenesis group. 
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Fig 3. (A) Calibration plot for two-photon intensity versus different concentrations (0–500 pM) of AuNCs in glass capillaries. (B) Calibration plot for 
photoacoustic (PA) amplitude versus different concentrations (0–500 pM) of AuNCs in glass capillaries. (C) Two-photon intensity as a function of culture 
time for the hMSCs labeled with AuNCs (lase power: 2%; scale bars: 50 µm). (D) PA amplitude as a function of culture time for the hMSCs labeled with 
AuNCs (scale bars: 100 µm). 
 
In vivo two-photon and photoacoustic mi-
croscopy of hMSCs labeled with AuNCs 
The hMSCs labeled with AuNCs (around 2.3 × 
104 particles per cell) were injected subcutaneously 
into the ear of a nude mouse. As shown in Figure 4A, 
individual cells could be well-resolved by two-photon 
microscopy. Figure 4B shows a calibration curve of 
two-photon intensity as a function of the number of 
cells injected. Since each cell had about the same 
number of AuNCs, the two-photon intensity in-
creased linearly as the number of cells increased (R2 = 
0.8955). To evaluate the capability of two-photon mi-
croscopy to track the distribution of AuNCs-labeled 
hMSCs in vivo, a human glioblastoma (brain tumor) 
was induced to form in a mouse ear by subcutaneous 
injection of U87-MG cells. At 1 week after the for-
mation of the tumor, around 1 × 105 hMSCs labeled 
with AuNCs were injected intravenously into the 
mouse via the tail vein. Two-photon images were 
collected 7 days later to follow the homing of hMSCs 
to the tumor region. Prior to imaging, the mouse was 
injected with rhodamine-dextran via the tail vein to 
label the blood vessels. Figure 4, C and D, shows a 
confocal micrograph of the vasculature (red) and a 
two-photon micrograph of the AuNCs-labeled hMSCs 
(green) in the tumor region, respectively. A 
co-registered image is shown in Figure 4E, and Figure 
4F shows an enlarged view of the area marked by the 
white dotted square in Figure 4E, indicating the 
co-localization of hMSCs with the tumor blood ves-
sels. 
The AuNCs-labeled hMSCs were also imaged in 
vivo using photoacoustic microscopy. As shown in 
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Figure 5A, the photoacoustic amplitude was linearly 
correlated with the number of hMSCs labeled with 
AuNCs (R2 = 0.9956). We then injected AuNCs-labeled 
hMSCs subcutaneously into a mouse ear and per-
formed optical-resolution photoacoustic imaging at a 
wavelength of 580 nm. Figure 5B shows coronal and 
sagittal maximum amplitude projection (MAP) im-
ages, respectively, revealing that both the blood ves-
sels of the mouse ear and the AuNCs-labeled hMSCs 
(shown as bright dots or patches) could be detected at 
such a wavelength. We then tracked the homing of the 
hMSCs to the glioblastoma region using du-
al-wavelength optical-resolution photoacoustic mi-
croscopy. The tumor was prepared as described above 
and photoacoustic imaging was performed 7 days 
after injection of the AuNCs-labeled hMSCs via tail 
vein. At 532 nm, both the blood vessels and 
AuNCs-labeled hMSCs were visible. Only the labeled 
cells could be observed at 638 nm due to the much 
weaker absorption of hemoglobin/deoxy-hemoglobin 
than AuNCs at this wavelength (Figure 1D). There-
fore, signals from each component could be easily 
separated in the photoacoustic images (Figure 5, C 
and D). We could further observe co-localization of 
tumor blood vessels and hMSCs in the co-registered 
images (Figure 5, E and F). 
The homing of hMSCs to the tumor region was 
also verified by histology. As shown in Supplemen-
tary Material: Figure S8, a few AuNCs-labeled cells 
(indicated by white arrows, dark green or blackish in 
color due to the presence of AuNCs) were found 
within the tumor region, and they were typically in 
close proximity to blood vessels (indicated by yellow 
arrowheads), indicating their migration from the tu-
mor vasculature to the surrounding tumor mass 
and/or their participation in the neovascularization of 
the tumor. 
 
 
Fig 4. (A) A representative two-photon projection image showing the AuNCs-labeled hMSCs subcutaneously injected into a mouse ear. (B) Calibration 
plot for two-photon intensity versus the number of subcutaneously injected hMSCs labeled with AuNCs. (C–E) Confocal and two-photon coronal pro-
jection images showing (C) blood vessels in a U87 brain tumor and (D) AuNCs-labeled hMSCs that homed to the tumor region, and (E) superimposed 
image. (F) An enlarged view showing the area indicated by white dotted square in (E). The tumor cells were inoculated subcutaneously in a mouse ear and 
allowed to develop for 1 week. Afterwards, the AuNCs-labeled hMSCs were injected intravenously and images were collected 7 days after injection. The 
blood vessels were fluorescently labeled by intravenous injection of rhodamine-dextran right before imaging. 
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Fig 5. (A) Calibration plot for photoacoustic (PA) amplitude versus the number of subcutaneously injected hMSCs labeled with AuNCs. (B) Representative 
PA coronal and sagittal MAP images showing the AuNCs-labeled hMSCs subcutaneously injected into a mouse ear. Laser excitation at a single wavelength 
at 580 nm could detect both blood and the AuNCs-labeled hMSCs (bright spots or patches). (C-E) PA coronal MAP images showing (C) blood vessels in 
a U87 brain tumor acquired at a wavelength of 532 nm and (D) the AuNCs-labeled hMSCs that homed to the tumor region acquired at a wavelength of 638 
nm, and (E) superimposed image. (F) An enlarged view showing the area as indicated by white dotted square in (E). The tumor cells were inoculated 
subcutaneously in a mouse ear and allowed to develop for 1 week. The AuNCs-labeled hMSCs were then injected intravenously and images were collected 
from the tumor region at 7 days after injection. MAP stands for ‘Maximum Amplitude Projection’. 
 
Discussion 
AuNCs are nanostructures with hollow interiors 
and porous walls; they can be readily prepared using 
a galvanic replacement reaction (Figure 1A). Due to 
their capability to carry bioactive substances within 
the hollow structures, AuNCs have been extensively 
used in drug delivery and cancer therapeutics [35, 36], 
as well as related cell uptake studies [37, 38]. Besides, 
they possess excellent optical properties including 
multi-photon luminescence and strong optical scat-
tering/absorption at tunable wavelengths (Figure 1, C 
and D). As such, they have also been actively ex-
plored as contrast agents for optical coherence to-
mography [39], multi-photon microscopy [34, 40], 
photoacoustic microscopy [41, 42], and sur-
face-enhanced Raman scattering [43]. Here we further 
demonstrated that AuNCs could be used to label stem 
cells in an effort to track these cells non-invasively, 
both in vitro and in vivo, using two-photon or photo-
acoustic microscopy. 
For any stem cell labeling technology to be prac-
tical, it is essential that the nanoparticles do not exert 
any toxic effect on the labeled cells. The potential 
toxicity of a few types of nanoparticles has been ob-
served although somewhat controversial. For exam-
ple, SPIO nanoparticles were shown to induce im-
paired differentiation of hMSCs via interference with 
signaling process [44]. Quantum dots containing 
cadmium can be toxic to cells due to the release of 
Cd2+ over time [25, 45]. Our cytotoxicity results 
showed that, incubation of AuNCs with hMSCs did 
not remarkably reduce the metabolic activity of the 
cells as determined by the MTT assay (Figure 1B), nor 
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the membrane integrity by analyzing G6PD released 
from the cells (Supplementary Material: Figure S1) 
within a reasonable dose. The minor toxicity of 
AuNCs to hMSCs was also demonstrated in a differ-
entiation assay, where the labeled cells were induced 
to differentiate into adipose or bone lineages. In either 
case there was no significant difference in the degree 
of differentiation comparing to the unlabeled cells 
(Figure 2). In addition, it is noted that AuNCs could 
retain in cultured hMSCs for at least 28 days in either 
the differentiation medium (Supplementary Material: 
Figure S4) or proliferation medium (Supplementary 
Material: Figure S5). During this period of time, the 
clearance of AuNCs by the cells was also negligible 
(Figure S5), unlike the marked exocytosis when using 
quantum dots smaller in size (10–20 nm) [21]. These 
results imply that our labeling technique based on 
AuNCs could potentially enable long-term tracking of 
hMSCs, which represents another important aspect of 
efficient stem cell labeling technology. 
Current imaging modalities based on nanoparti-
cle-labeling for monitoring stem cells are plagued by 
certain factors, including the relatively low sensitivity 
for MRI [24], the ionizing irradiation imposed by 
high-energy X-rays for micro-CT [27, 28], and shallow 
penetration depth for (confocal) fluorescence micros-
copy. Unlike conventional (confocal) fluorescence 
microscopy, multi-photon microscopy utilizes local-
ized non-linear excitation from a pulsed laser to excite 
fluorophores only at the focal plane, resulting in a 
quadratic dependence on the light intensity [46]. 
Photoacoustic microscopy, on the other hand, is a 
more recently developed imaging modality based on 
the detection of ultrasonic waves generated by an 
optically absorbing object irradiated by a pulsed or 
intensity-modulated laser [47]. Due to both the toler-
ance of optical scattering and the weak scattering of 
ultrasonic waves by biological tissues, photoacoustic 
microscopy can easily reach a much deeper depth 
than conventional microscopy based on pure optical 
imaging. Notably, the excitation peak of AuNCs was 
adjusted to a wavelength of 800 nm for both 
two-photon microscopy and photoacoustic micros-
copy, which could further improve the penetration 
depth of the two imaging modalities due to the rela-
tively low absorption of biological tissues at such a 
wavelength. Given the large optical absorption 
cross-section of AuNCs [48], it could also improve the 
detection sensitivity and therefore reduce the dose 
and potential cytotoxicity of the nanoparticles to the 
cells. 
Our in vitro experiments demonstrated that 
hMSCs labeled with AuNCs could be monitored by 
two-photon microscopy or photoacoustic microscopy 
at high resolution (Supplementary Material: Figure 
S6). Similar to two-photon microscopy, opti-
cal-resolution photoacoustic microscopy could 
achieve resolution as high as approximately 0.4 µm 
through tight optical focusing [31]. In addition to 
imaging their morphologies (Figure 3, C and D), we 
could further quantify the signals from the cells based 
on their two-photon luminescence intensity or pho-
toacoustic amplitude. The two-photon luminescence 
intensity or the photoacoustic amplitude decreased 
almost linearly over time (Figure 3, C and D), because 
the AuNCs were re-distributed and diluted into the 
daughter cells when the mother cells divided. Inter-
estingly, the standard deviation of the amount of 
AuNCs in each cell increased over time, indicating 
that the nanoparticles were presumably not distrib-
uted equally into the daughter cells upon the division 
of the mother cells. This result is similar to our study 
on the re-distribution of AuNCs in a brain tumor cell 
line [49]. It should be further noted that the AuNCs 
passively taken up by hMSCs were mainly distributed 
in the cytoplasm of the cells and the nuclei remained 
unlabeled. An investigation using TEM further re-
vealed that the majority of AuNCs were encapsulated 
within endosome-like structures (Supplementary 
Material: Figure S2), possibly due to their neutral 
surface charge. By modifying the surface properties 
(e.g., charges or ligands) of AuNCs, we can potentially 
control their cellular distributions to specific locations 
such as the plasma membrane, cytoplasm, and even 
nuclei. Importantly, using acoustic-resolution photo-
acoustic microscopy based on ultrasonic focusing, we 
could image the AuNCs-labeled hMSCs embedded 
more than 5 mm deep in tissues at a lateral resolution 
of approximately 100 µm (Supplementary Material: 
Figure S7). In fact, photoacoustic tomography can 
even image objects in biological tissues at a depth of 
several centimeters at the expense of further decreas-
ing the resolution [50, 51], which might be suitable for 
large animal studies and clinical applications. 
We also demonstrated the ability to image and 
track hMSCs in vivo. Using a glioblastoma model in 
the ear of a nude mouse, we could efficiently monitor 
the homing of AuNCs-labeled hMSCs to the tumor 
region post injection via tail vein using two-photon 
microscopy, while the blood vessels were simultane-
ously imaged using confocal microscopy after intra-
venous injection of rhodamine-dextran (Figure 4, 
C–F). In comparison, simultaneous imaging of 
AuNCs-labeled hMSCs and the tumor vasculature 
could be achieved using photoacoustic microscopy 
simply by dual-wavelength scanning (Figure 5, C–F), 
therefore eliminating any need to further label blood 
vessels with an exogenous contrast agent [52, 53]. This 
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unique feature comprises another major advantage of 
photoacoustic microscopy because the injection of any 
contrast agents into the blood stream may alter the 
hemodynamics of the vessels. Moreover, besides 
qualitative imaging of the blood vessels, quantitative 
and functional photoacoustic microscopy can also be 
performed to derive many parameters of the vascu-
lature, including blood vessel area [53], blood flow 
velocity [54], oxygen saturation [55], partial oxygen 
pressure [30, 55], and oxygen metabolism [56]. These 
parameters can be particularly important when stud-
ying the interactions between the infused stem cells 
and blood vessels, which are otherwise not easily ob-
tainable with other imaging modalities including 
two-photon microscopy, micro-CT, MRI, and PET. 
In summary, four photoacoustic microscopy 
systems were used in our current study. One of them 
is the subwavelength-resolution photoacoustic mi-
croscopy that can achieve a lateral resolution of ap-
proximately 400 nm through tight optical focusing, 
close to the optical diffraction limit (Figure S6B). 
However, the penetration depth of such a system is 
limited to micrometer-scale due to strong light scat-
tering. On the contrary, an acoustic-resolution pho-
toacoustic microscopy can achieve very deep pene-
tration over a few millimeters although the resolution 
has to be reduced to approximately 100 µm (Figure 
S7). By further decreasing the resolution, even deeper 
penetration on the scale of centimeters can be ob-
tained. The other two systems referred to as opti-
cal-resolution photoacoustic microscopy are in be-
tween these two extremes. They have high lateral 
resolutions of 3–5 µm and intermediate penetration 
depths of approximate 0.7–1 mm, which is well-suited 
for studies with cells and small animals. While the 
dual-modality system combining optical-resolution 
photoacoustic microscopy and confocal microscopy 
can be useful for regular photoacoustic imaging (Fig-
ure 3, B and D; Figure 5B) or in situations where ab-
sorption and fluorescence contrasts co-exist [57], the 
voice-coil optical-resolution photoacoustic microsco-
py is particularly suitable for live cell or animal im-
aging because of its fast scanning speed (Figure 5, 
C–F). Therefore, the photoacoustic microscopy sys-
tems are remarkably versatile in imaging samples 
over multiple scales depending on the specific appli-
cation. 
Conclusion 
We have demonstrated that AuNCs could be 
used to effectively label hMSCs for long-term tracking 
of the cells using non-invasive, two-photon or photo-
acoustic microscopy. The AuNCs did not show re-
markable cytotoxicity towards hMSCs as indicated by 
their high viability, membrane integrity, and differ-
entiation capability. With future development of an 
integrated dual modality imaging system that com-
bines two-photon and photoacoustic microscopy, we 
believe that our labeling and imaging techniques will 
find major applications in the field of (stem) cell 
tracking. 
Supplementary Material 
Fig. S1–S8. http://www.thno.org/v03p0532s1.pdf 
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